FDA launches new initiative to boost domestic drug manufacturing

FDA headquarters in Washington DC.

JHVEPhoto

The U.S. Food and Drug Administration (FDA) on Thursday announced FDA PreCheck, a program developed in response to a recent executive order signed by President Donald Trump to encourage domestic drug manufacturing through enhanced regulatory support.

As part of the

Leave a Reply

Your email address will not be published. Required fields are marked *